TLR7 and neoplasm: The toll-like receptor agonist TLR7/8a was coupled with a radiation-sensitive peptide hydrogel to modulate ITM, thereby regulating the repolarization of TAMs from M2 to M1 immunosuppressive tumor microenvironment